Zou Yuan Y - OmicsDI

Show results for

Unknown (778)
Proteomics (24)
Genomics (5)
Metabolomics (2)

Organisms

Mycobacterium tuberculosis SP7 (18)
Mycobacterium tuberculosis SP10 (18)
Mycobacterium tuberculosis SP13 (18)
Mycobacterium tuberculosis SP22 (18)
Chlamydomonas reinhardtii (18)
Enterococcus mundtii CRL35 (18)
Oncorhynchus tshawytscha (18)
Pseudomonas canadensis (18)
Human alphaherpesvirus 1 strain 17 (18)
Mycobacterium tuberculosis SP1 (18)
Marchantia polymorpha subsp. ruderalis (18)
Methylocystis sp. (18)
Exiguobacterium sp. SH31 (18)
Palaemonetes sp. common grass shrimp associated circular virus (18)
Amaranthus tricolor (18)
Clavibacter nebraskensis NCPPB 2581 (18)
Porites pukoensis (18)
Porphyromonas gingivalis W83 (18)
Human betaherpesvirus 5 (18)
Bothrops insularis (18)
Bothrops jararaca (18)
Bothrops jararacussu (18)
Bothrops cotiara (18)
Acinetobacter baumannii ATCC 19606 = CIP 70.34 = JCM 6841 (18)
Severe acute respiratory syndrome coronavirus 2 (18)
Bacillus spizizenii ATCC 6633 = JCM 2499 (18)
Dinosauria (18)
Homo sapiens (9)
Staphylococcus aureus (1)
Mus musculus (1)

Repository

pride (18)
iProX (6)
EGA (5)
MetaboLights (2)

Tissue

Cell culture (7)
Permanent cell line cell (3)
Macrophage (2)
Epithelial cell (2)
Pancreatic ductal cell (1)
Eye (1)
Serum (1)
Retina (1)
Fibroblast (1)
Hepatocyte (1)
Lung (1)
Liver (1)

Disease

Carcinoma (1)
Retinal disease (1)
Hepatocellular carcinoma (1)
Cervix carcinoma (1)
Breast cancer (1)
Colon cancer (1)

Technology Type

Mass Spectrometry (18)
Shotgun proteomics (8)
Bottom-up proteomics (4)
Mass spectrometry (2)
Data-independent acquisition (2)
Gel-based experiment (2)
Data-dependent acquisition (2)
Affinity purification coupled with mass spectrometry proteomics (2)
Illumina HiSeq 2000, Affymetrix SNP 6.0 (1)
Proteogenomics (1)
DiaPASEF (1)

Instrument Platform

Liquid Chromatography MS - (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2024 (7)
2025 (4)
2026 (3)
2023 (3)
2021 (3)
2022 (2)
2020 (2)
2018 (2)

CHEBI ID

CHEBI:35584 (2)
CHEBI:17308 (2)
CHEBI:12962 (2)
CHEBI:15682 (2)
CHEBI:30653 (2)
CHEBI:16345 (2)
CHEBI:30887 (2)
CHEBI:16255 (2)
CHEBI:21547 (2)
CHEBI:10072 (2)
CHEBI:17405 (2)
CHEBI:21553 (2)
CHEBI:28997 (2)
CHEBI:17621 (2)
CHEBI:6650 (2)
CHEBI:78320 (2)
CHEBI:16610 (2)
CHEBI:16543 (2)
CHEBI:17533 (2)
CHEBI:18237 (2)
CHEBI:17752 (2)
CHEBI:49033 (2)
CHEBI:22653 (2)
CHEBI:22660 (2)
CHEBI:18186 (2)
CHEBI:17376 (2)
CHEBI:32816 (2)
CHEBI:30769 (2)
CHEBI:27470 (2)
CHEBI:18107 (2)

Metabolite Name

N6-Acetyl-L-lysine (2)
Methionine sulfoxide (2)
4-Pyridoxic acid (2)
Xanthurenic acid (2)
(R)-(+)-Lactamide (1)
Dl-2-Hydroxybutyric acid (1)
3-Hydroxy-2-Methylbutanoic acid (1)
2-Ketohexanoic acid /2-oxohexanoic acid (1)
Dl-Aspartic acid (1)
Dl-Malic acid (1)
3-Carboxybenzadehyde (1)
3-Methylcrotonyl glycine (1)
3-(2-Hydroxyphenyl)-propionic acid (1)
Dl-4-Hydroxymandelic acid (1)
Dl-Norepinephrine (1)
4-Oxononanoic acid (1)
D(-)-Arginine (1)
Dl-3,4-Dihydroxymandelic acid (1)
Theobromine-d6 (1)
2,6-Dichlorobenzoic Acid (1)
3-Nitrobenzene sulphonate (1)
Phenylthiouracil (1)
5-Hydroxy-thiabendazole (1)
7z,10z,13z-Hexadecatrienoic Acid (1)
4,4-Methylene-Bis(2-Chloroaniline) (1)
Hypoxanthine-9-alpha-D-arabinofuranoside (1)
O-Benzyl-L-tyrosine (1)
17-alpha-Ethinylestradiol (1)
Cis-10-Nonadecenoic acid (1)
Sulfachinoxalin /Sulfaquinoxaline (1)

Release Date

2025 (135)
2022 (120)
2023 (102)
2020 (100)
2024 (82)
2021 (80)
2019 (34)
2018 (29)
2017 (21)
2016 (20)
2026 (16)
2015 (16)
2014 (14)
2012 (5)
2013 (2)
2011 (2)

Lab affiliation

Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Shenzhen Key Laboratory of Translational Medicine of Tumor, International Cancer Center, Department of Cell Biology and Genetics, School of Medicine, Shenzhen University, Shenzhen, 518055, China. (1)
1.Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China 2.State Key Laboratory of Natural and Biomimetic Drugs, Beijing 100191, China Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China (1)
1.Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China 2.State Key Laboratory of Natural and Biomimetic Drugs, Beijing 100191, China 3.Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China (1)
Department of Public Laboratory,Tianjin Medical University Cancer Institute and Hospital (1)
Biological mass spectrometry and proteomics group, Department of Chemistry High-resolution mass spectrometry platform, Core research facilities Guangdong provincial key laboratory for cell microenvironment and disease research Southern University of Science and Technology (SUSTech) 403, 1st research building, 1088 Xueyuan Rd., Nanshan, Shenzhen (1)
Department of Ophthalmology, the Second Affiliated Hospital of Army Medical University (1)
MOE Key Laboratory of Tumor Molecular Biology and Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, Jinan University, Guangzhou, China (1)
Department of Chemical Biology College of Chemistry and Molecular Engineering Peking University (1)
The Affiliated Hospital of Guizhou Medical University (1)
School of Medicine, Shanghai University, Shanghai 200444, China. (1)
Tianjin Medical University Cancer Institute and Hospital (1)
Sichuan Agricultural University (1)
Shanghai Institute for Materia Medica (1)
University of Electronic Science and Technology of China (1)
Sun Yat-sen University (1)
Professor, School of Pharmaceutical Sciences, Sun Yat-Sen University, China (1)
Center for Alzheimer's and Related Dementias (CARD), NIA and NINDS, NIH, Bethesda, Maryland, USA. (1)
Harvard Medical School (1)

Previous page
1 / 81
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 81
Next page

Sort by:

Relevance

Page size

Association of mTORC1‑dependent circulating protein levels with cataract formation: a mendelian randomization study.

Not available

S-EPMC9587558 | biostudies-literature

Comparative transcriptome among Euscaphis konishii Hayata tissues and analysis of genes involved in flavonoid biosynthesis and accumulation.

Not available

S-EPMC6327468 | biostudies-literature

HCT116-TGTA-proteomic profiling

HCT116 cells were treated with or without 50 μM TGTA for 24 hours. Cells were collected and the proteomes were then extracted for proteomic analysis.

ORGANISM(S): Homo sapiens (Human)

2025-07-16 | PXD063241 | Pride

Lc-ms Human cell line

Spatially resolved mapping of proteome turnover dynamics with subcellular precision

We report the development of prox-SILAC method that combines proximity-dependent protein labeling (APEX/HRP) with metabolic incorporation of stable isotopes (pulse-SILAC) to map newly synthesized proteins with subcellular spatial resolution. We apply prox-SILAC to investigate proteome dynamics in th...

ORGANISM(S): Homo sapiens (Human)

2024-01-26 | PXD037569 | Pride

Pusle-silac Proximity-dependent labeling Protein turnover

The association between entrapment and depression among migrant workers in China: a social rank theory based study.

Not available

S-EPMC8740036 | biostudies-literature

The effect of ALDH2 rs671 gene mutation on clustering of cardiovascular risk factors in a big data study of Chinese population: associations differ between the sexes.

Not available

S-EPMC7716427 | biostudies-literature

A Novel DNA Repair Gene Signature for Immune Checkpoint Inhibitor-Based Therapy in Gastric Cancer.

Not available

S-EPMC9168368 | biostudies-literature